Effect Of Delta Sodium on the Postoperative Outcomes in Liver Transplant Recipients
NCT ID: NCT04112004
Last Updated: 2019-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
342 participants
OBSERVATIONAL
2011-01-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Plasma Sodium and Sodium Administration in the ICU
NCT06037928
Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients
NCT02914782
Fluid Management in Patients Undergoing Cardiac Surgery
NCT02895659
The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney Transplantation
NCT06030609
Refeeding Like Syndrome in Acute Disease
NCT04966780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liver Transplant Recipients
All elective liver transplant recipients done between study period
Collecting sodium reports and outcome measures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collecting sodium reports and outcome measures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Records available
Exclusion Criteria
* All patients less than 18 years
* Re operated cases
* Pregnant patients
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Liver and Biliary Sciences, India
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karthik Ponnappan T
Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karthik T Ponnappan, DM
Role: PRINCIPAL_INVESTIGATOR
Institute of Liver and Biliary Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ILBS - Liver Transplant-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.